Table: Cosmos Pharmaceutical - 6-MTH group results

Cosmos Pharmaceutical

12/01/2024 06:00

Jan 12 (Reuters)- 
             Cosmos Pharmaceutical Corp. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Nov 30, 2023        Nov 30, 2022     May 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            476.43              404.02           916.00    
                 (+17.9 pct)         (+8.9 pct)       (+10.7 pct) 
  Operating         15.84               15.39            30.20    
                 (+2.9 pct)          (+2.7 pct)       (+0.2 pct)  
  Recurring         17.35               16.90            33.20    
                 (+2.6 pct)          (+2.5 pct)       (+0.3 pct)  
  Net               11.59               11.30            23.80    
                 (+2.6 pct)          (+0.5 pct)       (+0.0 pct)  
  EPS            292.53 yen          285.34 yen       601.03 yen  
  Ann Div                            100.00 yen       120.00 yen  
  -Q2 div         60.00 yen           42.50 yen                   
  -Q4 div                             57.50 yen        60.00 yen  
  
  NOTE - Cosmos Pharmaceutical Corp.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T